These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12684421

  • 1. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
    Fjällskog ML, Lejonklou MH, Oberg KE, Eriksson BK, Janson ET.
    Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
    [Abstract] [Full Text] [Related]

  • 2. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.
    Welin S, Fjällskog ML, Saras J, Eriksson B, Janson ET.
    Neuroendocrinology; 2006 Apr; 84(1):42-8. PubMed ID: 17047316
    [Abstract] [Full Text] [Related]

  • 3. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP, Chen YY, Chen W, Howell SB, Shively JE, Alberts DS.
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [Abstract] [Full Text] [Related]

  • 4. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP, Matthews KS, Kimball KJ, Conner MG, Baker AC, Barnes MN.
    Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
    [Abstract] [Full Text] [Related]

  • 5. Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas.
    Fjällskog ML, Hessman O, Eriksson B, Janson ET.
    Acta Oncol; 2007 Sep; 46(6):741-6. PubMed ID: 17653895
    [Abstract] [Full Text] [Related]

  • 6. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Bergmann F, Breinig M, Höpfner M, Rieker RJ, Fischer L, Köhler C, Esposito I, Kleeff J, Herpel E, Ehemann V, Friess H, Schirmacher P, Kern MA.
    Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
    [Abstract] [Full Text] [Related]

  • 7. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.
    Irsan I, Akisue T, Hara H, Fujimoto T, Imabori M, Doita M, Kuroda R, Fujioka H, Kawamoto T, Yamamoto T, Kurosaka M.
    Anticancer Res; 2007 Jan; 27(1A):423-9. PubMed ID: 17352263
    [Abstract] [Full Text] [Related]

  • 8. Tyrosine kinase expression in pulmonary metastases and paired primary tumors.
    Muehling BM, Toelkes S, Schelzig H, Barth TF, Sunder-Plassmann L.
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):228-31. PubMed ID: 19948538
    [Abstract] [Full Text] [Related]

  • 9. Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.
    Liegl B, Gülly C, Reich O, Nogales FF, Beham A, Regauer S.
    Histopathology; 2007 Mar; 50(4):448-52. PubMed ID: 17448020
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of STI571 on cell proliferation of human malignant fibrous histiocytoma cell lines.
    Kawamoto T, Akisue T, Marui T, Nakatani T, Hitora T, Fujita I, Kurosaka M, Yamamoto T.
    Anticancer Res; 2004 Mar; 24(5A):2675-9. PubMed ID: 15517872
    [Abstract] [Full Text] [Related]

  • 11. PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy.
    Wehler TC, Frerichs K, Graf C, Drescher D, Schimanski K, Biesterfeld S, Berger MR, Kanzler S, Junginger T, Galle PR, Moehler M, Gockel I, Schimanski CC.
    Oncol Rep; 2008 Mar; 19(3):697-704. PubMed ID: 18288404
    [Abstract] [Full Text] [Related]

  • 12. [Expression and significance of C-kit and platelet-derived growth factor receptor-beta (PDGFRbeta) in esophageal carcinoma].
    Zhang X, Rong TH, Zhang Y, Long H, Fu JH, Ling P, Zhang LJ, Yang MT, Zeng CG, Ma GW, Su XD, Li XD, Wang JY, Wen ZS, Zhao JM.
    Ai Zheng; 2006 Jan; 25(1):92-5. PubMed ID: 16405759
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    Liegl B, Leithner A, Bauernhofer T, Windhager R, Guelly C, Regauer S, Beham A.
    Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
    [Abstract] [Full Text] [Related]

  • 14. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH.
    Gynecol Oncol; 2004 Oct; 95(1):32-6. PubMed ID: 15385107
    [Abstract] [Full Text] [Related]

  • 15. PDGFR-alpha as a potential therapeutic target in uterine sarcomas.
    Adams SF, Hickson JA, Hutto JY, Montag AG, Lengyel E, Yamada SD.
    Gynecol Oncol; 2007 Mar; 104(3):524-8. PubMed ID: 17049587
    [Abstract] [Full Text] [Related]

  • 16. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
    Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM.
    Cancer; 2003 Aug 15; 98(4):758-64. PubMed ID: 12910520
    [Abstract] [Full Text] [Related]

  • 17. Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.
    Holtkamp N, Okuducu AF, Mucha J, Afanasieva A, Hartmann C, Atallah I, Estevez-Schwarz L, Mawrin C, Friedrich RE, Mautner VF, von Deimling A.
    Carcinogenesis; 2006 Mar 15; 27(3):664-71. PubMed ID: 16357008
    [Abstract] [Full Text] [Related]

  • 18. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK, Park YK.
    Pathol Res Pract; 2007 Mar 15; 203(3):127-34. PubMed ID: 17298867
    [Abstract] [Full Text] [Related]

  • 19. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG, Giordano TJ, Sanders D, Biermann S, Sondak VK, Trent JC, Yu D, Pollock RE, Baker L.
    Cancer; 2005 Feb 15; 103(4):830-8. PubMed ID: 15641030
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
    Srivastava A, Alexander J, Lomakin I, Dayal Y.
    Hum Pathol; 2001 Nov 15; 32(11):1184-9. PubMed ID: 11727256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.